| scholarly article | Q13442814 |
| P2093 | author name string | Dai H Chung | |
| Kwang Woon Kim | |||
| Jingbo Qiao | |||
| Sora Lee | |||
| Pritha Paul | |||
| Carmelle Romain | |||
| P2860 | cites work | Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma | Q24311457 |
| Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization | Q24564349 | ||
| The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells | Q27851718 | ||
| Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation | Q28285317 | ||
| Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study | Q33559116 | ||
| Aurora kinase inhibitors--rising stars in cancer therapeutics? | Q33647643 | ||
| Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). | Q33867046 | ||
| A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma | Q33944281 | ||
| Myc proteins as therapeutic targets | Q33997741 | ||
| Characteristics of stem cells from human neuroblastoma cell lines and in tumors | Q34928930 | ||
| Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. | Q35617266 | ||
| Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists | Q36642293 | ||
| Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines | Q36849233 | ||
| FAK is a critical regulator of neuroblastoma liver metastasis | Q36926116 | ||
| N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma | Q37038002 | ||
| The aurora kinase A regulates GSK-3beta in gastric cancer cells | Q37096754 | ||
| Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. | Q37594844 | ||
| Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma | Q37663791 | ||
| Biology of Aurora A kinase: implications in cancer manifestation and therapy | Q37701369 | ||
| PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer | Q37929638 | ||
| Regulation of gene transcription by the oncoprotein MYC. | Q37974026 | ||
| Effects of stable knockdown of Aurora kinase A on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells | Q39540720 | ||
| Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas | Q40875496 | ||
| Neuroblastoma | Q54265665 | ||
| Comparative genomic in situ hybridization of colon carcinomas with replication error | Q70786829 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 159-165 | |
| P577 | publication date | 2013-10-05 | |
| P1433 | published in | Journal of Pediatric Surgery | Q15761821 |
| P1476 | title | Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma | |
| P478 | volume | 49 |
| Q35790720 | ABCG2 impairs the activity of the aurora kinase inhibitor tozasertib but not of alisertib |
| Q37442586 | Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases |
| Q28543446 | Aurora kinases as targets in drug-resistant neuroblastoma cells |
| Q33618929 | Aurora kinases: novel therapy targets in cancers |
| Q38894287 | Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy |
| Q92305240 | CEP41-mediated ciliary tubulin glutamylation drives angiogenesis through AURKA-dependent deciliation |
| Q26771708 | Cell Proliferation in Neuroblastoma |
| Q38868413 | Clear cell renal cell carcinoma: identifying the gain of chromosome 20 on multiphasic MDCT. |
| Q37338152 | Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay |
| Q88426580 | Lack of associations between AURKA gene polymorphisms and neuroblastoma susceptibility in Chinese children |
| Q92402049 | MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment |
| Q89622450 | Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression |
| Q35493637 | Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer |
| Q34194552 | Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis |
| Q39208675 | The MYCN Protein in Health and Disease |
Search more.